Using publicly available databases, we could show that there is a trend of MTSS1 reduction after siRNA-mediated knockdown of AML1-ETO in human t(8;21) positive AML cells (Kasumi-1) (Fig 4A). This evidence concerns the gene RUNX1 and acute myeloid leukemia.